Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.767
+0.032 (4.41%)
At close: Jan 17, 2025, 4:00 PM
0.770
+0.002 (0.29%)
Pre-market: Jan 21, 2025, 8:28 AM EST
Seres Therapeutics Employees
Seres Therapeutics had 233 employees as of December 31, 2023. The number of employees decreased by 198 or -45.94% compared to the previous year.
Employees
233
Change (1Y)
-198
Growth (1Y)
-45.94%
Revenue / Employee
$542,167
Profits / Employee
-$109,335
Market Cap
131.02M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
MCRB News
- 5 days ago - Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale - GlobeNewsWire
- 12 days ago - Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates - GlobeNewsWire
- 5 weeks ago - Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Seres Therapeutics to Participate in Piper Sandler Healthcare Conference - GlobeNewsWire
- 2 months ago - Seres Therapeutics, Inc. (MCRB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Seres Therapeutics to Announce Third Quarter 2024 Financial Results and Business Updates on November 13, 2024 - GlobeNewsWire
- 4 months ago - Seres Therapeutics Announces Completion of VOWST™ Asset Sale to Société des Produits Nestlé S.A - GlobeNewsWire
- 4 months ago - Seres Therapeutics Stockholders Issue Open Letter to Board of Directors Regarding Reported Engagement With Nestlé - Business Wire